Jacek S Małyszko Selected Research

Jacek S Małyszko Research Topics

7	Chronic Kidney Failure (Chronic Renal Failure) 01/2007 - 09/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2009 - 01/2002
2	Dyslipidemias (Dyslipidemia) 12/2009 - 06/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2006 - 05/2005
2	Kidney Diseases (Kidney Disease) 11/2005 - 06/2002
2	Anemia 11/2005 - 01/2002
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2005 - 01/2004
2	Diabetic Nephropathies (Diabetic Nephropathy) 03/2004 - 08/2003
2	Atherosclerosis 03/2004 - 01/2004
2	Thrombosis (Thrombus) 01/2004 - 01/2002
2	Renal Insufficiency (Renal Failure) 01/2004 - 09/2002
1	Hypercalcemia (Milk Alkali Syndrome) 12/2017
1	Secondary Hyperparathyroidism 12/2017
1	Bone Resorption 01/2007
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2007
1	Cardiomyopathies (Cardiomyopathy) 01/2006
1	Iron Deficiencies 11/2005
1	Hypoxia (Hypoxemia) 11/2005
1	Inflammation (Inflammations) 11/2005
1	Diabetes Mellitus 05/2005
1	Obesity 05/2005
1	Acute Coronary Syndrome 05/2005
1	Hypertension (High Blood Pressure) 09/2002
1	Vitamin K Deficiency 09/2002
1	Bone Diseases (Bone Disease) 09/2002

3	Erythropoietin FDA Link 11/2005 - 01/2002
3	Hemostatics (Antihemorrhagics)IBA 01/2005 - 01/2002
2	Fibrinogen (Factor I)FDA Link 12/2009 - 03/2004
2	OsteocalcinIBA 01/2007 - 09/2002
2	Thrombin FDA Link 03/2004 - 08/2003
1	paricalcitol (Zemplar)FDA Link 12/2017
1	Cinacalcet (Sensipar)FDA Link 12/2017
1	CalciumIBA 12/2017
1	Protein Isoforms (Isoforms)IBA 01/2007
1	Alkaline PhosphataseIBA 01/2007
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2007
1	ApelinIBA 01/2006
1	HepcidinsIBA 11/2005
1	IronIBA 11/2005
1	AdiponectinIBA 05/2005
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	LeptinIBA 06/2004
1	AlbuminsIBA 03/2004
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2004
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 03/2004
1	AntithrombinsIBA 03/2004
1	Fibrinolysin FDA Link 03/2004
1	Triglycerides (Triacylglycerol)IBA 03/2004
1	Prothrombin (Factor II)IBA 03/2004
1	ThrombomodulinIBA 01/2004
1	E-SelectinIBA 01/2004
1	von Willebrand FactorIBA 01/2004
1	FibrinIBA 01/2004
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2004
1	P-SelectinIBA 01/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2002
1	Vitamin K FDA Link 09/2002
1	Biomarkers (Surrogate Marker)IBA 09/2002
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2002
1	LipidsIBA 06/2002
1	Oxidoreductases (Dehydrogenase)IBA 06/2002
1	HomocysteineIBA 01/2002

5	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2005 - 06/2002
3	Renal Dialysis (Hemodialysis) 12/2017 - 03/2004
3	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2009 - 03/2006
3	Peritoneal Dialysis 01/2005 - 01/2004
3	Conservative Treatment 03/2004 - 09/2002
1	Hemodiafiltration 03/2006
1	Therapeutics 11/2005
1	Organ Transplantation 09/2002